If a patient with retinitis pigmentosa experiences increasing peripheral vision loss, what explains why gene therapy targeting photoreceptor survival might fail to fully restore vision?

💡 Explanation

Gene therapy restores photoreceptor function but does not address subsequent degeneration of the bipolar cell network; because this network transmits signals, its loss prevents complete vision restoration. Therefore, the gene therapy, rather than failing directly on photoreceptors or drug delivery, is limited by downstream effects.

• If a pharmaceutical company develops a drug that inhibits the dimerization of intracellular steroid hormone receptors after ligand binding, which consequence follows?
• In a patient experiencing diabetic ketoacidosis, which outcome is most likely in the renal collecting duct regarding water reabsorption?
• If a patient's distal convoluted tubule and collecting duct are impermeable to water due to non-functional aquaporins, which consequence follows regarding plasma osmolality and ADH levels?
• If an Rh-negative pregnant woman carrying an Rh-positive fetus is not treated with Rho(D) immune globulin, which consequence follows during a subsequent pregnancy with another Rh-positive fetus?
• As an individual ages, why does the strength-generating capacity of skeletal muscle decline more rapidly than overall muscle mass loss?
• What distinguishes proteasomal degradation from chaperone-mediated autophagy in intracellular protein clearance?